← Leaderboards
Chang-En Yu
Va Puget Sound Healthcare System
$224,581
Attributed
$224,581
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $102.1K · FY2005–25$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$224,581 · 1
VA$0 · 2
By mechanism
R21$224,581 · 1
I01$0 · 2
Top collaborators
No co-investigators on record.
Most similar at Va Puget Sound Healthcare System
Same institution · by research overlap
- Cyrus P Zabetian$4,429,877
- Brian C. Kraemer$19,537,143
- Erik S Carlson$2,804,554
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposAllelesApolipoprotein EGene ExpressionEpigenetic ProcessGeneticGene Expression RegulationHuman Cell LineBiologicalGenesS Disease RiskPreventionProtein IsoformsVariantS DiseaseBrainAutopsyGenetic TranscriptionMolecularNeuronsBisulfiteGenetic VariantCellsCell Type
Grant awards (20)
Defining high- and low-risk APOE ÃÂõ4 haplotypes for AlzheimerâÃÂÃÂs disease$0
I01 · FY2025 · VA · contact PI
Redefining the Role of APOE RNA Transcripts in Alzheimer's Disease$0
I01 · FY2024 · VA · contact PI
Defining high- and low-risk APOE ÃÂõ4 haplotypes for AlzheimerâÃÂÃÂs disease$0
I01 · FY2024 · VA · contact PI
Redefining the Role of APOE RNA Transcripts in Alzheimer's Disease$0
I01 · FY2023 · VA · contact PI
Defining high- and low-risk APOE ÃÂõ4 haplotypes for AlzheimerâÃÂÃÂs disease$0
I01 · FY2023 · VA · contact PI
Defining high- and low-risk APOE ÃÂõ4 haplotypes for AlzheimerâÃÂÃÂs disease$0
I01 · FY2022 · VA · contact PI
Redefining the Role of APOE RNA Transcripts in Alzheimer's Disease$0
I01 · FY2022 · VA · contact PI
Redefining the Role of APOE RNA Transcripts in Alzheimer's Disease$0
I01 · FY2021 · VA · contact PI
Defining high- and low-risk APOE ÃÂõ4 haplotypes for AlzheimerâÃÂÃÂs disease$0
I01 · FY2021 · VA · contact PI
Redefining the Role of APOE RNA Transcripts in Alzheimer's Disease$0
I01 · FY2021 · VA · contact PI
Epigenetic component of the APOE gene in Alzheimer's disease$0
I01 · FY2018 · VA · contact PI
Epigenetic component of the APOE gene in Alzheimer's disease$0
I01 · FY2017 · VA · contact PI
Epigenetic component of the APOE gene in Alzheimer's disease$0
I01 · FY2016 · VA · contact PI
Epigenetic component of the APOE gene in Alzheimer's disease$0
I01 · FY2015 · VA · contact PI
The role of APOE locus genes regulation in Alzheimer's disease$0
I01 · FY2014 · VA · contact PI
The role of APOE locus genes regulation in Alzheimer's disease$0
I01 · FY2013 · VA · contact PI
The role of APOE locus genes regulation in Alzheimer's disease$0
I01 · FY2012 · VA · contact PI
The role of APOE locus genes regulation in Alzheimer's disease$0
I01 · FY2011 · VA · contact PI
APOE Gene-Based Haplotype Study in Alzeheimer's Disease$102,060
R21 · FY2005 · AG
APOE Gene-Based Haplotype Study in Alzeheimer's Disease$122,521
R21 · FY2004 · AG